EMEA-002217-PIP01-17-M02
Key facts
| Active substance |
In vitro expanded autologous human articular chondrocytes
|
| Therapeutic area |
Other
|
| Decision number |
P/0315/2021
|
| PIP number |
EMEA-002217-PIP01-17-M02
|
| Pharmaceutical form(s) |
Implant
|
| Condition(s) / indication(s) |
Treatment of cartilage disorders
|
| Route(s) of administration |
Intraarticular use
|
| Contact for public enquiries |
TETEC Tissue Engineering Technologies AG
E-mail: info@tetec-ag.de |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|